Evidence map›Paper›PMID 27887890›Full record

ArticleJournal of pharmaceutical sciences2017

Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.

Jamie L Betker, Thomas J Anchordoquy

Abstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Reducing off-target drug accumulation by exploiting a type-III interferon response.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  2. Article
  3. The Use of Lactose as an Alternative Coating for Nanoparticles.Journal of pharmaceutical sciences · 2020
    Article
  4. Article
  5. Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jamie L BetkerDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado 80045.
Thomas J AnchordoquyDepartment of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado 80045. Electronic address: Tom.Anchordoquy@ucdenver.edu.

Funding

Tumor-Homing Exosomes for Drug DeliveryR01EB016378 · NIBIB · UNIVERSITY OF COLORADO DENVER · PI ANCHORDOQUY, THOMAS, GRANER, MICHAEL W. · 2013 to 2016
$1.5M
Exploiting Cholesterol Nanodomains to Improve TargetingR01GM093287 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI ANCHORDOQUY, THOMAS · 2011 to 2014
$1.1M
NIBIB NIH HHS R01 EB016378NIGMS NIH HHS R01 GM093287
6 · The paper itself

Abstract

Repetitive administration is routinely used to maintain therapeutic drug levels, but previous studies have documented an accelerated blood clearance of some lipid-based delivery systems under these conditions. To assess the effect of repetitive administration, non-PEGylated lipoplexes (+/-0.5) were administered 4 times via tail vein injection at 3-day intervals to immunocompetent BALB/c mice bearing 4T1 tumors. This study measured the effect of repeat administration of nontargeted lipoplexes on clearance, cytokine/chemokine response, plasmid distribution, reporter gene expression, and liver toxicity. We do not observe a refractory period or a statistically significant difference in blood clearance between the first administration and subsequent injections of this lipoplex formulation, consistent with the absence of a cytokine/chemokine response. However, we do see a significant effect on both plasmid accumulation and expression, an enhancement of 26-fold and 10-fold in tumor plasmid levels and expression, respectively, after 4 injections as compared to that after a single injection. In addition, in vivo imaging suggests that expression in other organs had diminished rapidly 72 h after each administration, in contrast to relatively constant expression in the tumor. Taken together, the findings indicate that gene delivery to tumors can be dramatically enhanced by employing repetitive administration.

Indexed as

AnimalsDrug Administration ScheduleImmunocompetenceLipidsMiceMice, Inbred BALB CNeoplasmsPolyethylene GlycolsLipidspolyethylene glycol 2000Polyethylene Glycolsbiodistributioncholesterol nanodomainclearancegene deliveryimmunocompetentlipoplexliver toxicityrefractory periodrepeat dosingsphingosine

Identifiers

PMID27887890
PMCPMC5657239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.